Zing Health Appoints Seasoned Healthcare Finance Executive Mete Sahin as Chief Financial Officer

Today Zing Health, a physician-led Medicare Advantage HMO plan, announced that Mete Sahin has been named Chief Financial Officer. Sahin brings 25 years of healthcare finance expertise to further Zing Health’s goal of providing affordable, holistic and inclusive care to improve community health for underserved populations.

Sahin has deep experience assessing, developing and implementing strategies for healthcare companies, from private equity fundraising, financing, M&A and business integrations to Medicare Advantage bidding, internal controls, financial systems and reporting. Sahin’s knowledge in pricing health insurance plans and controlling costs will further Zing Health’s ability to implement innovative Medicare Advantage plans that work in the community to make sure members get the right care at the right time.

“As a consultant during our Chicago launch, Mete was instrumental in raising capital and building solid financial processes and systems,” said Dr. Eric Whitaker, Zing Health co-founder and CEO. “As an experienced healthcare finance executive, Mete knows the playbook for running a comprehensive insurance plan that improves outcomes for its members at lower cost.  We look forward to working with him in a full-time capacity as he builds a healthcare finance team with tremendous Medicare Advantage experience and proven performance.”

Sahin previously served as CFO of Advance Health, overseeing its growth and 2018 merger with CenseoHealth to form Signify Health, a New Mountain Capital portfolio company. In this role, Sahin was responsible for creating cost-efficient processes that enabled Advance Health to meet complex care needs through early, person-to-person interventions. These innovations ranged from aligning the incentives of medical providers to improve patient health to heading off potential adverse drug interactions or hospital visits. The network of nurse practitioners worked with doctors in the nation’s leading Medicare Advantage programs to identify gaps and health risks for hundreds of thousands of patients.

Prior to his tenure with Advance Health, Sahin was CFO of XLHealth Corp., helping its subsidiary Care Improvement Plus grow, innovate and stage a rapid financial turnaround.  In six years, XLHealth grew from a $600 million operator of Medicare Advantage special needs plans to a $2 billion plus company acquired by UnitedHealth Group. As CFO of UnitedHealth’s dental, vision and Medicaid business segments, Sahin reorganized offerings to become efficient and more responsive. He was also vice president-finance and controller of Lifemark Corp. before it was absorbed into UnitedHealth.

Mr. Sahin earned his master’s degree from the University of Surrey in England and a bachelor’s degree from the University of Southern California in Los Angeles.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.